Immunization, Hib3 in Sweden
Sweden: Immunization, Hib3 was 95.0% in 2024. ▲ Rising
Immunization, Hib3 in Sweden, 1991–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Sweden recorded 95.0% for immunization, hib3 in 2024.
The figure is up 1.1% on the previous year and down 3.1% over ten years.
Over the whole period, immunization, hib3 in Sweden peaked at 99.0% in 1993 and was at its lowest, 55.0%, in 1991.
Sweden ranks 56th of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 34 years of available data.
Immunization, Hib3 in Sweden, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1991 | 55.0% | — |
| 1992 | 90.0% | +63.6% |
| 1993 | 99.0% | +10.0% |
| 1994 | 99.0% | +0.0% |
| 1995 | 99.0% | +0.0% |
| 1996 | 99.0% | +0.0% |
| 1997 | 99.0% | +0.0% |
| 1998 | 99.0% | +0.0% |
| 1999 | 98.0% | -1.0% |
| 2000 | 98.0% | +0.0% |
| 2001 | 98.0% | +0.0% |
| 2002 | 98.0% | +0.0% |
| 2003 | 99.0% | +1.0% |
| 2004 | 99.0% | +0.0% |
| 2005 | 98.0% | -1.0% |
| 2006 | 98.0% | +0.0% |
| 2007 | 98.0% | +0.0% |
| 2008 | 98.0% | +0.0% |
| 2009 | 98.0% | +0.0% |
| 2010 | 98.0% | +0.0% |
| 2011 | 98.0% | +0.0% |
| 2012 | 98.0% | +0.0% |
| 2013 | 98.0% | +0.0% |
| 2014 | 98.0% | +0.0% |
| 2015 | 98.0% | +0.0% |
| 2016 | 98.0% | +0.0% |
| 2017 | 97.0% | -1.0% |
| 2018 | 97.0% | +0.0% |
| 2019 | 97.0% | +0.0% |
| 2020 | 97.0% | +0.0% |
| 2021 | 98.0% | +1.0% |
| 2022 | 94.0% | -4.1% |
| 2023 | 94.0% | +0.0% |
| 2024 | 95.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 93.0% | 55.0% | 99.0% | 9 |
| 2000s | 98.2% | 98.0% | 99.0% | 10 |
| 2010s | 97.7% | 97.0% | 98.0% | 10 |
| 2020s | 95.6% | 94.0% | 98.0% | 5 |
Countries ranked near Sweden
More health data for Sweden
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8581 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,109 deaths per 1,000 people (2090)
- Number of infants who die before age 1 30 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.028 units per person (2025)
- Population ages 05-09, male, annual growth rate -0.91 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0297 units per person (2025)
- Population ages 10-14, female, annual growth rate -0.4271 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Sweden?
- Immunization, hib3 in Sweden was 95.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Sweden?
- The highest recorded value was 99.0% in 1993.
- What is the lowest immunization, hib3 recorded in Sweden?
- The lowest recorded value was 55.0% in 1991.
- How does Sweden rank for immunization, hib3?
- Sweden ranks 56th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Sweden?
- Over the last ten years it is down 3.1%. The long-run trend across the full record is rising.
- Where does this Sweden data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 34 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.